An 8-week Multicenter, Randomized, Double-blind, Active Controlled, Parallel Group, Forced Titration Study to Evaluate the Efficacy and Safety of Aliskiren/Amlodipine/HCTZ Compared to Aliskiren/Amlodipine in US Minority Patients With Stage 2 Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 07 Jun 2011
At a glance
- Drugs Aliskiren/amlodipine; Aliskiren/amlodipine/hydrochlorothiazide; Amlodipine
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Acronyms ASCENT
- 25 Aug 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 25 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jul 2009 New trial record